Trimanos offers the Contract Research Organisation (CRO) "a third generation" support solution, based on a new business model for the CRO. This model effects a shift in the operational culture from sequential to parallel work flow, resulting in a truly collaborative, "community of interest" across the whole operation of a trial. In consequence, incentives for quality, and speed to market, are aligned and overall performance improves
As the age of the blockbuster drug is also coming to an end, Sponsors need to rethink their business process. Many will not make the cut. The CRO can be more agile and responsive to change, especially if it can base its business process on expertise quality rather than volume and throughput.
This Trimanos believes, changes the CRO's role from that of a manager of "peaks and troughs" of a Sponsor's business, to being one of specialist value-add provider of trial management know-how and technology. This reflects the increasingly specialist, indication specific, team-based culture of healthcare systems worldwide, while also providing a route to improved margins.
Emerging Markets
Trimanos has been tested in a wide variety of settings and is designed to meet the needs of emerging markets for clinical research. These markets have set out stakeholder driven models of collaboration which Trimanos is ideally suited to support.
Operational Features
Trimanos focuses on expertise in trial administration. It supports training and reference in GCP, effective site management, collaborative working between CRO, site and - where required - Sponsor. The system architecture promotes continuous process management and high quality communications, whether of data or clinical content.
Trimanos can assist you:
Project manage
Recruit and retain sites
Eliminate double-keying of data
Improve error trapping
Speed up query resolution.
Best Practices and Preserving Institutional Memory
Trimanos emphasizes best practices, as well as GCP compliance, an emphasis it expresses through its focus on "Good Clinical Research Practice", GCRP. Because its supports collaborative working, it addresses a common weakness in trial management, the failure to preserve institutional memory. This can be very expensive as each time a CRO starts a trial it is as if it starts from the beginning, each time a site is recruited, it has to learn from scratch. Trimanos provides a resource that makes the process of trial start up significantly easier.
Operational Coherence
The highly distributed nature of multi-site studies has tended to foster a sense of fragmentation in trial management, and a lack of coherence between the operational requirements of a trial and its medico-scientific objective. This challenge becomes even more daunting when the Sponsor is trying to shorten time to market, and reduce cost.
Trimanos brings coherence and consistency into a task that can easily become fragmented and dislocated. Because it is expert led, it focuses on in-process quality and reliability in outcome. Because it has standardized key processes and fitted them to GCP compliance requirements it can make site to site comparison and uniformity of communications much easier to action, sustain and manage. Because it is browser-based, and fully web-enabled, it can greatly facilitate workflow and enhanced productivity.
Value Driven
Perhaps Trimanos's greatest strength lies in its intangible values: by rethinking the clinical research process from a stakeholder point of view, Trimanos has built a system on a commitment to clinical research as both a public good and a sustainable industry. At a time of broken trust and confidence, this commitment is essential to the continuity of an essential process for us all - finding out more about health and about the prevention, management and curing of disease.